Author: admin

  • Jamie Reed – 2016 Parliamentary Question to the Department of Health

    Jamie Reed – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jamie Reed on 2016-07-13.

    To ask the Secretary of State for Health, what estimate his Department has made of the annual cost to people with Type 1 diabetes who self-fund a continuous glucose monitor.

    Nicola Blackwood

    No estimate has been made of the annual cost to people with Type 1 diabetes who self-fund a continuous glucose monitor.

    In August 2015, the National Institute for Health and Care Excellence provided updated guidelines for both Type 1 diabetes and for children and young people with diabetes. In both, the cost effectiveness, as well as the clinical effectiveness, of continuous glucose monitoring was assessed. Both sets of guidelines outline specific clinical situations where the clinical and cost effectiveness justify consideration of the use of the technology.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, what recent discussions he has had with the Food and Drink Federation on tackling obesity.

    Nicola Blackwood

    Details of all Ministerial meetings with external stakeholders are published quarterly in arrears on the GOV.UK website. The latest publication which covers meetings between January and March 2016 can be found at:

    https://www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2016

    “

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, what discussions he has had with NHS England on support for research into immuno-oncology treatments for head and neck cancer.

    David Mowat

    The Department has had no specific discussions with NHS England on this topic.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, if he will assess the potential merits of making the drug AK-219 available on the NHS to treat persistent coughs.

    Nicola Blackwood

    AF-219 is still undergoing clinical trials for the treatment of chronic coughs and it would be premature to comment on its future availability on the National Health Service.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, what assessment he has had made of the effect of the introduction of the HPV vaccination on reducing the incidence of head and neck cancer among men who have sex with men.

    Nicola Blackwood

    In November 2015 the Joint Committee for Vaccination and Immunisation advised that a human papillomavirus (HPV) vaccination programme should be introduced for men who have sex with men (MSM) attending genito-urinary medicine clinics. In preparing this advice, the Committee took into account mathematical models that considered the likely effect of the vaccination programme on anal, penile and oropharyngeal (including tonsillar) cancers. The models suggested that introduction of HPV vaccination for MSM is likely to decrease the incidence of oropharyngeal cancers in the long term.

  • Helen Jones – 2016 Parliamentary Question to the Department of Health

    Helen Jones – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Helen Jones on 2016-07-13.

    To ask the Secretary of State for Health, pursuant to the Answer of 11 July 2016 to Question 41992, what the reasons are for the time taken to publish the childhood obesity strategy; and if he will make a statement.

    Nicola Blackwood

    Obesity is a complex problem with many factors having an impact. For this reason, it is important to ensure that the Childhood Obesity Strategy is as comprehensive as possible. The Prime Minister and the Cabinet will be working over the coming days and weeks to establish their priorities and how we deliver on these commitments.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, what steps he is taking to reduce the incidence of people being diagnosed with enlarged prostates.

    David Mowat

    In the majority of men, the prostate grows larger with age, and patients usually present to a general practitioner with symptoms of an enlarged prostate after the age of 50. Symptoms can include: weak urine flow; needing to urinate more often, especially at night; a feeling that your bladder has not emptied properly; and, difficulty starting to urinate. Some men find their symptoms are manageable and cause few problems, other find their symptoms worsening, which can impact on wellbeing and quality of life.

    For patients who need treatment, there are a number of approaches available including lifestyle and dietary adjustments, medicines and surgery.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, if he will make an assessment of the potential merits of the use of pig organ transplants for humans.

    Nicola Blackwood

    The Department has no plans to make such an assessment.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, what discussions he has had with his EU counterparts on co-operation on developing and making available new drugs to treat breast cancer.

    Nicola Blackwood

    Many new medicines in Europe, including medicines to treat breast cancer, are licensed by the European Medicines Agency (EMA). The EMA brings together scientific experts from across Europe by working closely with the national regulatory authorities, in a partnership known as the European medicines regulatory network. The Medicines and Healthcare products Regulatory Agency is an active participant in this network and its discussions.

    “

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

    To ask the Secretary of State for Health, what discussions he has had with pharmaceutical companies on steps to reduce the cost of cancer drugs for the NHS.

    Nicola Blackwood

    The Department has frequent discussions with representatives of the United Kingdom pharmaceutical industry as well as with individual pharmaceutical companies on a range of topics. We want to see the latest and most advanced drugs made available to National Health Service patients in a way that ensures value for money.